IL5 and neoplasm: The enhanced production of IL-5 and IL-13 was present in the splenic ILC2s of the tumor-challenged mice regardless of the disappearance of increased numbers of splenic ILC2s over time, which had been observed in tumor-free mice upon the tumor challenge (Figure 2).